Literature DB >> 20133632

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Alexander Ploss1, Salman R Khetani, Christopher T Jones, Andrew J Syder, Kartik Trehan, Valeriya A Gaysinskaya, Kathy Mu, Kimberly Ritola, Charles M Rice, Sangeeta N Bhatia.   

Abstract

Hepatitis C virus (HCV) remains a major public health problem, affecting approximately 130 million people worldwide. HCV infection can lead to cirrhosis, hepatocellular carcinoma, and end-stage liver disease, as well as extrahepatic complications such as cryoglobulinemia and lymphoma. Preventative and therapeutic options are severely limited; there is no HCV vaccine available, and nonspecific, IFN-based treatments are frequently ineffective. Development of targeted antivirals has been hampered by the lack of robust HCV cell culture systems that reliably predict human responses. Here, we show the entire HCV life cycle recapitulated in micropatterned cocultures (MPCCs) of primary human hepatocytes and supportive stroma in a multiwell format. MPCCs form polarized cell layers expressing all known HCV entry factors and sustain viral replication for several weeks. When coupled with highly sensitive fluorescence- and luminescence-based reporter systems, MPCCs have potential as a high-throughput platform for simultaneous assessment of in vitro efficacy and toxicity profiles of anti-HCV therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133632      PMCID: PMC2840339          DOI: 10.1073/pnas.0915130107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells.

Authors:  S N Bhatia; U J Balis; M L Yarmush; M Toner
Journal:  FASEB J       Date:  1999-11       Impact factor: 5.191

Review 2.  Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

Authors:  E L LeCluyse
Journal:  Eur J Pharm Sci       Date:  2001-07       Impact factor: 4.384

3.  Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro.

Authors:  Sylvie Rumin; Pascale Berthillon; Eiji Tanaka; Kendo Kiyosawa; Mary-Anne Trabaud; Thierry Bizollon; Christian Gouillat; Philippe Gripon; Christiane Guguen-Guillouzo; Geneviève Inchauspé; Christian Trépo
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

4.  Replication and multiplication of hepatitis C virus genome in human foetal liver cells.

Authors:  S Iacovacci; M Sargiacomo; I Parolini; A Ponzetto; C Peschle; G Carloni
Journal:  Res Virol       Date:  1993 Jul-Aug

5.  Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.

Authors:  K G Hadlock; R E Lanford; S Perkins; J Rowe; Q Yang; S Levy; P Pileri; S Abrignani; S K Foung
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.

Authors:  Ajay Madan; Richard A Graham; Kathleen M Carroll; Daniel R Mudra; L Alayne Burton; Linda A Krueger; April D Downey; Maciej Czerwinski; Jameson Forster; Maria D Ribadeneira; Liang-Shang Gan; Edward L LeCluyse; Karl Zech; Philmore Robertson; Patrick Koch; Lida Antonian; Greg Wagner; Li Yu; Andrew Parkinson
Journal:  Drug Metab Dispos       Date:  2003-04       Impact factor: 3.922

7.  Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells.

Authors:  Hideki Yokoo; Tadashi Kondo; Kazuyasu Fujii; Tesshi Yamada; Satoru Todo; Setsuo Hirohashi
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

8.  p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Authors:  I C Hsu; T Tokiwa; W Bennett; R A Metcalf; J A Welsh; T Sun; C C Harris
Journal:  Carcinogenesis       Date:  1993-05       Impact factor: 4.944

9.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

10.  Susceptibility of human liver cell cultures to hepatitis C virus infection.

Authors:  G Carloni; S Iacovacci; M Sargiacomo; G Ravagnan; A Ponzetto; C Peschle; M Battaglia
Journal:  Arch Virol Suppl       Date:  1993
View more
  97 in total

Review 1.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Authors:  Philip Meuleman; Maria Teresa Catanese; Lieven Verhoye; Isabelle Desombere; Ali Farhoudi; Christopher T Jones; Timothy Sheahan; Katarzyna Grzyb; Riccardo Cortese; Charles M Rice; Geert Leroux-Roels; Alfredo Nicosia
Journal:  Hepatology       Date:  2011-12-16       Impact factor: 17.425

4.  New horizons for studying human hepatotropic infections.

Authors:  Ype P de Jong; Charles M Rice; Alexander Ploss
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 5.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

Review 6.  Physiologically relevant human tissue models for infectious diseases.

Authors:  Melody Mills; Mary K Estes
Journal:  Drug Discov Today       Date:  2016-06-25       Impact factor: 7.851

Review 7.  Advances in nucleoside monophosphate prodrugs as anti-HCV agents.

Authors:  Drew R Bobeck; Raymond F Schinazi; Steven J Coats
Journal:  Antivir Ther       Date:  2010

8.  Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.

Authors:  Timothy Sheahan; Naoko Imanaka; Svetlana Marukian; Marcus Dorner; Peng Liu; Alexander Ploss; Charles M Rice
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

Review 9.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

10.  Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

Authors:  Amir Shlomai; Robert E Schwartz; Vyas Ramanan; Ankit Bhatta; Ype P de Jong; Sangeeta N Bhatia; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.